search again

Prostate Cancer Urine And PSA Risk Test

Nationwide rates for HCPCS 0113U

Estimates the risk that a man has prostate cancer, to help decide whether a biopsy is warranted. It measures two RNA markers in urine, PCA3 and the TMPRSS2-ERG fusion, and combines them with the PSA protein level from blood into a single risk score.

Rates data updated June 2026.

Facilitymedian $1,175 · 10th–90th $646$3,4670%20%10th90th$1,175Professionalmedian $617 · 10th–90th $417$9120%20%40%10th90th$617$0.0$0.2$2.0$20.0$200.0$2.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$645.65
Median
$1,318.26
Typical High
$3,467.37
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489.78
Median
$616.60
Typical High
$870.96
BCBS
Setting
Facility
Modifier
Global
Typical Low
$707.95
Median
$1,023.29
Typical High
$3,467.37
BCBS
Setting
Professional
Modifier
Global
Typical Low
$269.15
Median
$302.00
Typical High
$1,000.00
Cigna
Setting
Facility
Modifier
Global
Typical Low
$537.03
Median
$1,479.11
Typical High
$3,388.44
Cigna
Setting
Professional
Modifier
Global
Typical Low
$891.25
Median
$1,122.02
Typical High
$2,089.30
United
Setting
Facility
Modifier
Global
Typical Low
$354.81
Median
$758.58
Typical High
$912.01
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$912.01